The content is available as a PDF (305.1 KB).
References
- 1.Apostolopoulos V., Xiang S. D., Selomulya C., et al. Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010;2(3):205–218. doi: 10.1002/wnan.88. [DOI] [PubMed] [Google Scholar]
- 2.Bozkir A., Saka O. M. Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics. Drug Deliv. 2004;11:107–112. doi: 10.1080/10717540490280705. [DOI] [PubMed] [Google Scholar]
- 3.Centelles M. N., Qian C., Campanero M. A., et al. New methodologies to characterize the effectiveness of the gene transfer mediated by DNA-chitosan nanoparticles. Int J Nanomed. 2008;3(4):451–460. doi: 10.2147/ijn.s3445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Chinsangaram J., Beard C., Mason P. W., et al. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J Virol. 1998;72:4454–4457. doi: 10.1128/jvi.72.5.4454-4457.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Doel T. R. FMD Vaccines. Virus Res. 2003;91:81–89. doi: 10.1016/S0168-1702(02)00261-7. [DOI] [PubMed] [Google Scholar]
- 6.Hashimoto M., Morimoto M., Saimoto H., et al. Gene transfer by DNA/mannosylated chitosan complexes into mouse peritoneal macrophages. Biotechnol Lett. 2006;28:815–821. doi: 10.1007/s10529-006-9006-x. [DOI] [PubMed] [Google Scholar]
- 7.Jang M. K., Jeong Y. I., Cho C. S., et al. The preparation and characterization of low molecular and water soluble free-amine chitosan. Bull Korean Chem Soc. 2002;23:914–916. doi: 10.5012/bkcs.2002.23.6.914. [DOI] [Google Scholar]
- 8.Jiang H. L., Kang M. L., Quan J. S., et al. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization. Biomaterials. 2008;29:1931–1939. doi: 10.1016/j.biomaterials.2007.12.025. [DOI] [PubMed] [Google Scholar]
- 9.Jiang L., Qian F., He X., et al. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice. J Gene Med. 2007;9:253–264. doi: 10.1002/jgm.1017. [DOI] [PubMed] [Google Scholar]
- 10.Kim T. H., Jin H., Kim H. W., et al. Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Mol Cancer Ther. 2006;5:1723–1732. doi: 10.1158/1535-7163.MCT-05-0540. [DOI] [PubMed] [Google Scholar]
- 11.Lu S., Song X., Cao D., et al. Preparation of Water-Soluble Chitosan. J Appl Polymer Sci. 2004;91:3497–3503. doi: 10.1002/app.13537. [DOI] [Google Scholar]
- 12.McCullough K. C., Sobrino F. Immunology of Foot and Mouth Disease. In: Sobrino F., Domingo E., editors. Foot and Mouth Disease current perspectives. England: Horizon Bioscience; 2004. pp. 173–222. [Google Scholar]
- 13.Mady M. M., Darwish M. M., Khalil S., et al. Biophysical studies on chitosan coated liposomes. Eur Biophysic J. 2009;38:1127–1133. doi: 10.1007/s00249-009-0524-z. [DOI] [PubMed] [Google Scholar]
- 14.OIE Manual. 2008. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter No.2.1.5. (Revised version May 2012), 6th Edition, Volume 1 and 2.
- 15.Reed L. J., Muench H. A. A simple method of estimating 50% end points. Am J Hyg. 1938;27:493–497. [Google Scholar]
- 16.Tan M. C., Mommaas A. M., Drijfhout J. W., et al. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol. 1997;27:2426–2435. doi: 10.1002/eji.1830270942. [DOI] [PubMed] [Google Scholar]
- 17.Zhao F, Wu Y, Zhang X, et al. 2011. Enhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2. Hum Vaccine. 1: 7(10). [DOI] [PubMed]